Other Species / Isoforms
  UCK2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K33-ub
SGGTASGkSSVCAkI
0 2
UCK2 (human) SGGTASGkSSVCAkI K33-ub
UCK2 (mouse) SGGTASGKSSVCAKI K33
UCK2 (rat) SGGTASGKSSVCAKI K33
K39-ub
GkSSVCAkIVQLLGQ
0 2
UCK2 (human) GkSSVCAkIVQLLGQ K39-ub
UCK2 (mouse) GKSSVCAKIVQLLGQ K39
UCK2 (rat) GKSSVCAKIVQLLGQ K39
Y51-p
LGQNEVDyRQkQVVI
0 1
UCK2 (human) LGQNEVDyRQkQVVI Y51-p
UCK2 (mouse) LGQNEVDYHQKQVVI Y51
UCK2 (rat) LGQNEVDYHQKQVVI Y51
K54-ub
NEVDyRQkQVVILSQ
0 11
UCK2 (human) NEVDyRQkQVVILSQ K54-ub
UCK2 (mouse) NEVDYHQKQVVILSQ K54
UCK2 (rat) NEVDYHQKQVVILSQ K54
T69
DSFYRVLTSEQkAkA
0 1
UCK2 (human) DSFYRVLTSEQkAkA T69
UCK2 (mouse) DSFYRVLtsEQkAKA T69-p
UCK2 (rat) DSFYRVLTSEQKAKA T69
S70
SFYRVLTSEQkAkAL
0 1
UCK2 (human) SFYRVLTSEQkAkAL S70
UCK2 (mouse) SFYRVLtsEQkAKAL S70-p
UCK2 (rat) SFYRVLTSEQKAKAL S70
K73-ub
RVLTSEQkAkALkGQ
0 13
UCK2 (human) RVLTSEQkAkALkGQ K73-ub
UCK2 (mouse) RVLtsEQkAKALkGQ K73-ub
UCK2 (rat) RVLTSEQKAKALKGQ K73
K75-ub
LTSEQkAkALkGQFN
0 4
UCK2 (human) LTSEQkAkALkGQFN K75-ub
UCK2 (mouse) LtsEQkAKALkGQFN K75
UCK2 (rat) LTSEQKAKALKGQFN K75
K78-ub
EQkAkALkGQFNFDH
0 104
UCK2 (human) EQkAkALkGQFNFDH K78-ub
UCK2 (mouse) EQkAKALkGQFNFDH K78-ub
UCK2 (rat) EQKAKALKGQFNFDH K78
K96-ub
FDNELILkTLkEITE
0 3
UCK2 (human) FDNELILkTLkEITE K96-ub
UCK2 (mouse) FDNELIFKTLKEITE K96
UCK2 (rat) FDNELIFKTLKEITE K96
K99-ub
ELILkTLkEITEGkT
0 10
UCK2 (human) ELILkTLkEITEGkT K99-ub
UCK2 (mouse) ELIFKTLKEITEGKT K99
UCK2 (rat) ELIFKTLKEITEGKT K99
K105-ub
LkEITEGkTVQIPVY
0 3
UCK2 (human) LkEITEGkTVQIPVY K105-ub
UCK2 (mouse) LKEITEGKTVQIPVY K105
UCK2 (rat) LKEITEGKTVQIPVY K105
T157-p
QMKLFVDtDADTrLS
0 1
UCK2 (human) QMKLFVDtDADTrLS T157-p
UCK2 (mouse) QMKLFVDTDADTRLS T157
UCK2 (rat) QMKLFVDTDADTRLS T157
R162-m1
VDtDADTrLSRRVLR
0 1
UCK2 (human) VDtDADTrLSRRVLR R162-m1
UCK2 (mouse) VDTDADTRLSRRVLR R162
UCK2 (rat) VDTDADTRLSRRVLR R162
K202-ub
EFCLPTKkYADVIIP
0 26
UCK2 (human) EFCLPTKkYADVIIP K202-ub
UCK2 (mouse) EFCLPTKKYADVIIP K202
UCK2 (rat) EFCLPTKKYADVIIP K202
K235-ub
ILNGGPSkRQtNGCL
0 4
UCK2 (human) ILNGGPSkRQtNGCL K235-ub
UCK2 (mouse) ILNGGLSkRQTNGYL K235-ub
UCK2 (rat) ILNGGLSKRQTNGYL K235
T238-p
GGPSkRQtNGCLNGy
0 1
UCK2 (human) GGPSkRQtNGCLNGy T238-p
UCK2 (mouse) GGLSkRQTNGYLNGY T238
UCK2 (rat) GGLSKRQTNGYLNGY T238
Y245-p
tNGCLNGytPsRKRQ
0 25
UCK2 (human) tNGCLNGytPsRKRQ Y245-p
UCK2 (mouse) TNGYLNGYTPSRKRQ Y245
UCK2 (rat) TNGYLNGYTPSRKRQ Y245
T246-p
NGCLNGytPsRKRQA
0 18
UCK2 (human) NGCLNGytPsRKRQA T246-p
UCK2 (mouse) NGYLNGYTPSRKRQA T246
UCK2 (rat) NGYLNGYTPSRKRQA T246
S248-p
CLNGytPsRKRQAsE
0 5
UCK2 (human) CLNGytPsRKRQAsE S248-p
UCK2 (mouse) YLNGYTPSRKRQAsE S248
UCK2 (rat) YLNGYTPSRKRQASE S248
S254-p
PsRKRQAsESSSRPH
Upstream
1 36
Treatment
  • EGF
  • nocodazole
  • U0126
UCK2 (human) PsRKRQAsESSSRPH S254-p
UCK2 (mouse) PSRKRQAsEsSSRPH S254-p
UCK2 (rat) PSRKRQASESSSRPH S254
S256
RKRQAsESSSRPH__
0 1
UCK2 (human) RKRQAsESSSRPH__ S256
UCK2 (mouse) RKRQAsEsSSRPH__ S256-p
UCK2 (rat) RKRQASESSSRPH__ S256